Back
FINEOS Corporation Holdings Plc Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
61
FNCHF
FINEOS Corporation Holdings Plc
Last Price:
$1.85
Seasonality Move:
-14.2%
Buy
90
KYMR
Kymera Therapeutics, Inc.
Last Price:
$94.38
Seasonality Move:
7.7%
Buy
61
FINEOS Corporation Holdings Plc (FNCHF)
is a Buy
Is FINEOS Corporation Holdings Plc a Buy, Sell or Hold?
-
The current FINEOS Corporation Holdings Plc [FNCHF] share price is $1.85. The Score for FNCHF is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
FNCHF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
FNCHF Stock Price Chart
What is FINEOS Corporation Holdings Plc's stock price today?
-
The FINEOS Corporation Holdings Plc share price today is $1.85The current trend is relatively stagnant and FNCHF is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $94.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
FNCHF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 100 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.85 - 1.85) | Sell |
| Bollinger Bands (100): | (1.85 - 1.85) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 86.88 | Buy |
| Chaikin Money Flow: | -462379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.8 - 71.72) | Buy |
| Bollinger Bands (100): | (43.38 - 63.26) | Buy |
FNCHF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.85 | Sell |
| 20-day SMA: | 1.85 | Sell |
| 50-day SMA: | 1.85 | Sell |
| 200-day SMA: | 1.66 | Buy |
| 8-day EMA: | 1.85 | Sell |
| 20-day EMA: | 1.85 | Buy |
| 50-day EMA: | 1.85 | Buy |
| 200-day EMA: | 1.69 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70 | Buy |
| 20-day SMA: | 66.61 | Buy |
| 50-day SMA: | 61.97 | Buy |
| 200-day SMA: | 44.25 | Buy |
| 8-day EMA: | 72.36 | Buy |
| 20-day EMA: | 67.57 | Buy |
| 50-day EMA: | 61.93 | Buy |
| 200-day EMA: | 49.42 | Buy |
FINEOS Corporation Holdings Plc Earnings Growth & FNCHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
FINEOS Corporation Holdings Plc Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||